Yeshiva University: Investigating a Mutation That Leads to Breast Cancer
May 14, 2020
May 14, 2020
BRONX, New York, May 14 -- Yeshiva University's Albert Einstein College of Medicine issued the following news release:
MLL3, the gene that codes for the histone methyltransferase MLL3, is frequently mutated in breast cancer and in other major cancers as well.
Recent studies by the laboratory of Wenjun Guo, Ph.D., associate professor of cell biology and a member of the Gottesman Institute for Stem Cell Biology and Regenerative Medicine at Einstein, have shown that MLL3 i . . .
MLL3, the gene that codes for the histone methyltransferase MLL3, is frequently mutated in breast cancer and in other major cancers as well.
Recent studies by the laboratory of Wenjun Guo, Ph.D., associate professor of cell biology and a member of the Gottesman Institute for Stem Cell Biology and Regenerative Medicine at Einstein, have shown that MLL3 i . . .